Acute fatty liver of pregnancy: an update on mechanisms

Acute fatty liver of pregnancy (AFLP), characterized by hepatic microvesicular steatosis, is a sudden catastrophic illness occurring almost exclusively in the third trimester of pregnancy. Defective fatty acid oxidation in the fetus has been shown to be associated with this disease. Since the placenta has the same genetic makeup as the fetus and as AFLP patients generally recover following delivery, we hypothesized that the placenta might be involved in pathogenesis of this disease. In an animal model of hepatic microvesicular steatosis (using sodium valproate), we found that microvesicular steatosis results in mitochondrial structural alterations and oxidative stress in subcellular organelles of the liver. In placentas from patients with AFLP, we observed placental mitochondrial dysfunction and oxidative stress in subcellular organelles. In addition, defective placental fatty acid oxidation results in accumulation of toxic mediators such as arachidonic acid. Escape of these mediators into the maternal circulation might affect the maternal liver resulting in microvesicular steatosis.

[1]  A. Goel,et al.  How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis? , 2010, Gut.

[2]  P. Haggarty.  Fatty acid supply to the human fetus. , 2010, Annual review of nutrition.

[3]  P. Eskelin,et al.  Elevated hydroxyacylcarnitines in a carrier of LCHAD deficiency during acute liver disease of pregnancy - a common feature of the pregnancy complication? , 2010, Molecular genetics and metabolism.

[4]  A. Ramachandran,et al.  Liver injury in acute fatty liver of pregnancy: Possible link to placental mitochondrial dysfunction and oxidative stress , 2010, Hepatology.

[5]  P. Cunningham,et al.  Long chain PUFA transport in human term placenta. , 2009, The Journal of nutrition.

[6]  S. Hillaire.  A prospective national study of acute fatty liver of pregnancy in the UK. , 2008 .

[7]  J. Ibdah.  Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. , 2006, World journal of gastroenterology.

[8]  C. Eapen,et al.  Oxidative stress in experimental liver microvesicular steatosis: Role of mitochondria and peroxisomes , 2006, Journal of gastroenterology and hepatology.

[9]  R. Wanders,et al.  Fatty acid oxidation in the human fetus: Implications for fetal and adult disease , 2006, Journal of Inherited Metabolic Disease.

[10]  L. Wilkins-Haug,et al.  Fetal Fatty Acid Oxidation Defects and Maternal Liver Disease in Pregnancy , 2006, Obstetrics and gynecology.

[11]  M. Stridsberg,et al.  Increased lipolysis in non‐obese pregnant women studied in the third trimester , 2005, BJOG : an international journal of obstetrics and gynaecology.

[12]  J. Cline,et al.  Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. , 2005, Gastroenterology.

[13]  R. Wanders,et al.  Inhibitory effect of 3-hydroxyacyl-CoAs and other long-chain fatty acidβ-oxidation intermediates on mitochondrial oxidative phosphorylation , 1996, Journal of Inherited Metabolic Disease.

[14]  H. Waterham,et al.  High activity of fatty acid oxidation enzymes in human placenta: Implications for fetal-maternal disease , 2003, Journal of Inherited Metabolic Disease.

[15]  D. Rakheja,et al.  Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. , 2003, American journal of physiology. Endocrinology and metabolism.

[16]  J. Ibdah,et al.  Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. , 2002, JAMA.

[17]  D. Rakheja,et al.  Long-Chain L-3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency: A Molecular and Biochemical Review , 2002, Laboratory Investigation.

[18]  A. Maitra,et al.  Absence of the G1528C (E474Q) Mutation in the α-Subunit of the Mitochondrial Trifunctional Protein in Women with Acute Fatty Liver of Pregnancy , 2002, Pediatric Research.

[19]  E. R. Baumgartner,et al.  Perioperative management of a child with very‐long‐chain acyl‐coenzyme A dehydrogenase deficiency , 2002, Paediatric anaesthesia.

[20]  M. Morgan,et al.  Prospective study of liver dysfunction in pregnancy in Southwest Wales. , 2002, Gut.

[21]  I. Tein.  Metabolic Disease in the Fetus Predisposes to Maternal Hepatic Complications of Pregnancy , 2000, Pediatric Research.

[22]  J. Reddy,et al.  Peroxisomal and Mitochondrial Fatty Acid β-Oxidation in Mice Nullizygous for Both Peroxisome Proliferator-activated Receptor α and Peroxisomal Fatty Acyl-CoA Oxidase , 1999, The Journal of Biological Chemistry.

[23]  S. Walsh,et al.  Placental mitochondria as a source of oxidative stress in pre-eclampsia. , 1998, Placenta.

[24]  H. Kalimo,et al.  Pathology of skeletal muscle and impaired respiratory chain function in long-chain 3-hydroxyacyl-coa dehydrogenase deficiency with the G1528C mutation , 1996, Neuromuscular Disorders.

[25]  D. Pessayre,et al.  Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. , 1996, Journal of hepatology.

[26]  D. Pessayre,et al.  Effects of female sex hormones on mitochondria: possible role in acute fatty liver of pregnancy. , 1995, The American journal of physiology.

[27]  D. Turnbull,et al.  Acute fatty liver of pregnancy and long‐chain 3‐hydroxyacyl–coenzyme A dehydrogenase deficiency , 1994, Hepatology.

[28]  J. Ribalta,et al.  Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. , 1994, Gut.

[29]  D. Pessayre,et al.  Decreased mitochondrial oxidation of fatty acids in pregnant mice: Possible relevance to development of acute fatty liver of pregnancy , 1993, Hepatology.

[30]  B. Wilcken,et al.  Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. , 1991, Gastroenterology.